BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37818926)

  • 1. Red blood cell alloimmunization in myelodysplastic syndromes: Associations with sex, DAT-positivity, and increased transfusion needs.
    Rydén J; Clements M; Wikman A; Hellström-Lindberg E; Edgren G; Höglund P
    Transfusion; 2023 Nov; 63(11):2040-2051. PubMed ID: 37818926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
    Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
    Singhal D; Kutyna MM; Chhetri R; Wee LYA; Hague S; Nath L; Nath SV; Sinha R; Wickham N; Lewis ID; Ross DM; Bardy PG; To LB; Reynolds J; Wood EM; Roxby DJ; Hiwase DK
    Haematologica; 2017 Dec; 102(12):2021-2029. PubMed ID: 28983058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
    Lin Y; Saskin A; Wells RA; Lenis M; Mamedov A; Callum J; Buckstein R
    Vox Sang; 2017 Jan; 112(1):79-86. PubMed ID: 28097704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
    Leal I; Dos Santos TD; Gilli S; Castilho L
    Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome.
    Adkins BD; Mehta A; Selesky M; Vittitow S; Smolkin ME; Ratcliffe SJ; Luckey CJ
    Transfusion; 2022 Dec; 62(12):2470-2479. PubMed ID: 36278434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization.
    Sirianni MFM; Sippert E; Blos B; Gonçalves FRV; Hamerschlak N; Kutner J; Castilho L; Marti LC; Bonet-Bub C
    Transfus Med; 2022 Oct; 32(5):394-401. PubMed ID: 35778823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].
    Arriaga F; Bonanad S; Larrea L; de la Rubia J; López F; Sanz MA; Sanz G; Marty ML
    Sangre (Barc); 1995 Jun; 40(3):177-80. PubMed ID: 7570268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
    Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
    Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunization in blood transfusion-dependent β thalassemia major patients in Sana'a City-Yemen.
    Almorish MAW; Al-Absi B; Elkhalifa AME; Alhamidi AH; Abdelrahman M
    Sci Rep; 2024 Jan; 14(1):1005. PubMed ID: 38200206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease.
    Zheng Y; Gossett JM; Chen PL; Barton M; Ryan M; Yu J; Kang G; Hankins JS; Chou ST
    Blood Adv; 2023 Sep; 7(17):4799-4808. PubMed ID: 37023228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
    Leisch M; Weiss L; Lindlbauer N; Jungbauer C; Egle A; Rohde E; Greil R; Grabmer C; Pleyer L
    Leuk Res; 2017 Aug; 59():12-19. PubMed ID: 28535394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohematological challenges in COVID infected patients.
    Pandey P; Mandal S; Ranjan S; Setya D; Kumari S; Marik A
    Transfus Apher Sci; 2023 Oct; 62(5):103729. PubMed ID: 37286441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of pediatric transfusion-dependent thalassemia patients in a large academic center.
    Zarrabian D; Hanna M
    J Clin Lab Anal; 2023 Sep; 37(17-18):e24962. PubMed ID: 37665129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand.
    Teawtrakul N; Songdej D; Hantaweepant C; Tantiworawit A; Lauhasurayotin S; Torcharus K; Sripornsawan P; Sutcharitchan P; Surapolchai P; Komvilaisak P; Saengboon S; Pongtanakul B; Charoenkwan P;
    Transfusion; 2022 Oct; 62(10):2039-2047. PubMed ID: 35986658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic Syndrome.
    Rozovski U; Ben-Tal O; Kirgner I; Mittelman M; Hareuveni M
    Isr Med Assoc J; 2015 Oct; 17(10):624-7. PubMed ID: 26665317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red Blood Cell Alloimmunization in Korean Patients With Myelodysplastic Syndrome and Liver Cirrhosis.
    Kim HY; Cho EJ; Chun S; Kim KH; Cho D
    Ann Lab Med; 2019 Mar; 39(2):218-222. PubMed ID: 30430787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Ang AL; Lim CY; Ng WY; Lam JCM
    Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of laboratory characteristics, analysis of alloimmunization, and searching for predictors related to survival in patients with Autoimmune Hemolytic Anemia.
    Durigon G; Sekine L; Franz JPM; Fogliatto LM; da Rocha Silla LM
    Transfus Apher Sci; 2023 Oct; 62(5):103741. PubMed ID: 37271665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.